Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1997Journal of Antimicrobial ChemotherapyOpen Access

Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDavid M. LivermoreUniversity of East Anglia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

David M. Livermore (1997) studied this question.

synapsesocial.com/papers/6a7d36a8a3b6fd5035d5aa5ahttps://doi.org/10.1093/jac/40.3.335
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms1989 · 34 citations
  2. 2Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa1993 · 30 citations
  3. 3National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa1995 · 54 citations
  4. 4Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa1995 · 645 citations
  5. 5Structure-Based Design of β-Lactamase Inhibitors. 1. Synthesis and Evaluation of Bridged Monobactams1998 · 75 citations